FindTrial
Sign In

Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer(ACTS-GC)

Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer(ACTS-GC)

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080220047
Enrollment
Unknown
Registered
2005-09-07
Start date
2005-09-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

investigational material(s) Generic name etc : TS-1 (tegafur + gimeracil + oteracil potassium) INN of investigational material : TS-1:tegafur, gimeracil, oteracil potassium Therapeutic category code :

Sponsors

Taiho Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with Stage II (except T1), IIIA or IIIB gastric cancer who received a surgery of curative resection (curability A or B).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy and safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026